167 results
424B3
QLGN
Qualigen Therapeutics Inc
3 May 24
Prospectus supplement
1:50pm
. acquired, via the recapitalization, a substantial majority of the shares of the Company. Ritter/Qualigen Therapeutics common stock, which
POS AM
QLGN
Qualigen Therapeutics Inc
30 Apr 24
Prospectus update (post-effective amendment)
6:58pm
, a substantial majority of the shares of the Company. Ritter/Qualigen Therapeutics common stock, which was previously traded on the Nasdaq Capital Market under
8-K
EX-10.3
QLGN
Qualigen Therapeutics Inc
16 Apr 24
Entry into a Material Definitive Agreement
4:10pm
, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority … as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably
8-K
EX-10.2
QLGN
Qualigen Therapeutics Inc
16 Apr 24
Entry into a Material Definitive Agreement
4:10pm
which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals … who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members
8-K
EX-10.1
wsw jdbhnukwdokjo
27 Feb 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10.3
r8cv59z git
27 Feb 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10.2
yb5y7e5
27 Feb 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-10.1
7bqc8g
7 Dec 23
Entry into a Material Definitive Agreement
4:15pm
424B3
d9ybzuj9h70r6
29 Sep 23
Prospectus supplement
4:30pm
POS AM
eya56jsjma yg
1 Sep 23
Prospectus update (post-effective amendment)
4:15pm
8-K
EX-10.1
017dwlbv fa5pibv9l
26 Jul 23
Entry into a Material Definitive Agreement
5:25pm
8-K
qmx8y70wxyl3o kp7a
26 Jul 23
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-99.2
vnat wpe1i3
26 Jul 23
Entry into a Material Definitive Agreement
5:25pm